ALS Blood Biomarkers Could Lead to Better Management of Disease
A new study identifies the most effective blood biomarkers for diagnosing and predicting the progression of ALS.
A new study identifies the most effective blood biomarkers for diagnosing and predicting the progression of ALS.
Helius Medical Technologies Inc. has surpassed initial enrollment targets for its stroke registrational program evaluating PoNS Therapy, a novel neuromodulation approach to improve gait and balance in stroke patients.
AI is on the verge of true breakthroughs in the diagnosis, prognosis, and treatment of neurological disorders, including Parkinson’s and stroke.
Hop On A Cure’s contribution will specifically be used for the ALS CURE Project’s 3ML Project.
Read MoreJogo Health and Mayo Clinic hope this initiative will lead to advancements in treating tremors with AI-driven digital therapeutics.
Read MoreResearchers in Korea have developed an innovative robotic rehabilitation system to enhance the strength and dexterity of individuals with tremors.
Read MoreAn international team of researchers led by Penn Medicine will investigate the link between traumatic brain injuries (TBI) and Alzheimer’s disease and related dementias (ADRD) over the next five years with a $10 million grant.
Read MoreThe real-world study evaluated the impact of this approach to address neuromuscular walking challenges associated with foot drop.
Read MoreThe PSS Referral Tool uses red, green, and yellow classification levels to help rehab professionals prioritize patients at risk for post-stroke spasticity.
Read MoreThe study will explore the use of novel digital biomarkers to monitor disease, with the aim of providing greater objectivity in multiple sclerosis assessment.
Read MoreStony Brook researchers are using computer and AI technologies to create a Caregiving Robot Assistant (CART) for ALS patients and their caregivers.
Read MoreHop On a Cure has a new financial contribution toward research at Massachusetts General Hospital Department of Neurology’s Sean M. Healey & AMG Center for ALS.
Read MoreThis program will provide patients with access to Neurologic Music Therapy, using music and evidenced-based interventions to improve areas of movement, language, and cognition.
Read MoreThis research aims to monitor cognitive workload using a wearable cyber-physical system with a novel sensor to improve concussion recovery.
Read MoreWomen are three times more likely than men to get diagnosed with multiple sclerosis. Now, rates of MS are on the rise among Black women.
Read MoreA preliminary study investigates if people who have headaches after a concussion have higher levels of iron in areas of the brain, a sign of injury to brain cells.
Read MoreNSCF will send human brain organoids derived from patients with two different types of degenerative brain diseases—Parkinson’s and PPMS—to the orbiting laboratory.
Read MoreThe company says the clearance is supported by safety and effectiveness data of the exoskeleton in patients with spinal cord injuries at levels T5 to L5 and has been evaluated in more than 500 patients.
Read More